115 related articles for article (PubMed ID: 23504501)
1. Discovery of potential targets of selenomethionine-mediated chemoprevention in colorectal carcinoma mouse model using proteomics analysis.
Rahman MM; Seo YR
Carcinogenesis; 2013 Jul; 34(7):1575-84. PubMed ID: 23504501
[TBL] [Abstract][Full Text] [Related]
2. Proteome analysis and tissue microarray for profiling protein markers associated with lymph node metastasis in colorectal cancer.
Pei H; Zhu H; Zeng S; Li Y; Yang H; Shen L; Chen J; Zeng L; Fan J; Li X; Gong Y; Shen H
J Proteome Res; 2007 Jul; 6(7):2495-501. PubMed ID: 17542627
[TBL] [Abstract][Full Text] [Related]
3. The anticancer effects of sodium selenite and selenomethionine on human colorectal carcinoma cell lines in nude mice.
Yang Y; Huang F; Ren Y; Xing L; Wu Y; Li Z; Pan H; Xu C
Oncol Res; 2009; 18(1):1-8. PubMed ID: 19911698
[TBL] [Abstract][Full Text] [Related]
4. Proteomic analysis of colorectal cancer metastasis: stathmin-1 revealed as a player in cancer cell migration and prognostic marker.
Tan HT; Wu W; Ng YZ; Zhang X; Yan B; Ong CW; Tan S; Salto-Tellez M; Hooi SC; Chung MC
J Proteome Res; 2012 Feb; 11(2):1433-45. PubMed ID: 22181002
[TBL] [Abstract][Full Text] [Related]
5. Combinational chemoprevention effect of celecoxib and an oral antiangiogenic LHD4 on colorectal carcinogenesis in mice.
Kim JY; Alam F; Chung SW; Park J; Jeon OC; Kim SY; Son WC; Byun Y
Anticancer Drugs; 2014 Oct; 25(9):1061-71. PubMed ID: 25003253
[TBL] [Abstract][Full Text] [Related]
6. Use of multiple reaction monitoring for multiplex analysis of colorectal cancer-associated proteins in human feces.
Ang CS; Rothacker J; Patsiouras H; Gibbs P; Burgess AW; Nice EC
Electrophoresis; 2011 Aug; 32(15):1926-38. PubMed ID: 21538981
[TBL] [Abstract][Full Text] [Related]
7. [Differential proteomic analysis of human colorectal carcinoma cell lines SW620 and SW480 with different metastatic potentials].
Qu LJ; Ding YQ; Liang L
Di Yi Jun Yi Da Xue Xue Bao; 2005 Oct; 25(10):1211-5, 1220. PubMed ID: 16234091
[TBL] [Abstract][Full Text] [Related]
8. Serum proteome analysis for profiling protein markers associated with lymph node metastasis in colorectal carcinoma.
Zhao L; Liu Y; Sun X; Peng K; Ding Y
J Comp Pathol; 2011; 144(2-3):187-94. PubMed ID: 21074777
[TBL] [Abstract][Full Text] [Related]
9. Cell surface proteomics identifies glucose transporter type 1 and prion protein as candidate biomarkers for colorectal adenoma-to-carcinoma progression.
de Wit M; Jimenez CR; Carvalho B; Belien JA; Delis-van Diemen PM; Mongera S; Piersma SR; Vikas M; Navani S; Pontén F; Meijer GA; Fijneman RJ
Gut; 2012 Jun; 61(6):855-64. PubMed ID: 21890811
[TBL] [Abstract][Full Text] [Related]
10. Development of an antibody proteomics system using a phage antibody library for efficient screening of biomarker proteins.
Imai S; Nagano K; Yoshida Y; Okamura T; Yamashita T; Abe Y; Yoshikawa T; Yoshioka Y; Kamada H; Mukai Y; Nakagawa S; Tsutsumi Y; Tsunoda S
Biomaterials; 2011 Jan; 32(1):162-9. PubMed ID: 20933274
[TBL] [Abstract][Full Text] [Related]
11. Identification of 5-fluorouracil response proteins in colorectal carcinoma cell line SW480 by two-dimensional electrophoresis and MALDI-TOF mass spectrometry.
Wong CS; Wong VW; Chan CM; Ma BB; Hui EP; Wong MC; Lam MY; Au TC; Chan WH; Cheuk W; Chan AT
Oncol Rep; 2008 Jul; 20(1):89-98. PubMed ID: 18575723
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of hepatic-metastasis risk of colorectal cancer upon the protein signature of PI3K/AKT pathway.
Kang B; Hao C; Wang H; Zhang J; Xing R; Shao J; Li W; Xu N; Lu Y; Liu S
J Proteome Res; 2008 Aug; 7(8):3507-15. PubMed ID: 18570457
[TBL] [Abstract][Full Text] [Related]
13. Contribution of enzymic alpha, gamma-elimination reaction in detoxification pathway of selenomethionine in mouse liver.
Okuno T; Kubota T; Kuroda T; Ueno H; Nakamuro K
Toxicol Appl Pharmacol; 2001 Oct; 176(1):18-23. PubMed ID: 11578145
[TBL] [Abstract][Full Text] [Related]
14. Colorectal cancer proteomics, molecular characterization and biomarker discovery.
Barderas R; Babel I; Casal JI
Proteomics Clin Appl; 2010 Feb; 4(2):159-78. PubMed ID: 21137041
[TBL] [Abstract][Full Text] [Related]
15. Novel proteomic strategy reveal combined alpha1 antitrypsin and cathepsin D as biomarkers for colorectal cancer early screening.
Xie LQ; Zhao C; Cai SJ; Xu Y; Huang LY; Bian JS; Shen CP; Lu HJ; Yang PY
J Proteome Res; 2010 Sep; 9(9):4701-9. PubMed ID: 20666480
[TBL] [Abstract][Full Text] [Related]
16. Proteomics-based strategy to identify biomarkers and pharmacological targets in leukemias with t(4;11) translocations.
Yocum AK; Busch CM; Felix CA; Blair IA
J Proteome Res; 2006 Oct; 5(10):2743-53. PubMed ID: 17022645
[TBL] [Abstract][Full Text] [Related]
17. Connective tissue growth factor acts as a therapeutic agent and predictor for peritoneal carcinomatosis of colorectal cancer.
Lin BR; Chang CC; Chen RJ; Jeng YM; Liang JT; Lee PH; Chang KJ; Kuo ML
Clin Cancer Res; 2011 May; 17(10):3077-88. PubMed ID: 21558398
[TBL] [Abstract][Full Text] [Related]
18. Metformin suppresses azoxymethane-induced colorectal aberrant crypt foci by activating AMP-activated protein kinase.
Hosono K; Endo H; Takahashi H; Sugiyama M; Uchiyama T; Suzuki K; Nozaki Y; Yoneda K; Fujita K; Yoneda M; Inamori M; Tomatsu A; Chihara T; Shimpo K; Nakagama H; Nakajima A
Mol Carcinog; 2010 Jul; 49(7):662-71. PubMed ID: 20564343
[TBL] [Abstract][Full Text] [Related]
19. Chemoprevention for advanced CR neoplasia.
Moshkowitz M; Shapira S; Arber N
Best Pract Res Clin Gastroenterol; 2011 Aug; 25(4-5):623-30. PubMed ID: 22122776
[TBL] [Abstract][Full Text] [Related]
20. New prognosis biomarkers identified by dynamic proteomic analysis of colorectal cancer.
Peng Y; Li X; Wu M; Yang J; Liu M; Zhang W; Xiang B; Wang X; Li X; Li G; Shen S
Mol Biosyst; 2012 Nov; 8(11):3077-88. PubMed ID: 22996014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
